(CDW) CDW - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US12514G1085
Stock:
Total Rating 36
Risk 71
Buy Signal -0.82
| Risk 5d forecast | |
|---|---|
| Volatility | 28.9% |
| Relative Tail Risk | -3.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.01 |
| Alpha | -51.29 |
| Character TTM | |
|---|---|
| Beta | 1.200 |
| Beta Downside | 1.387 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.47% |
| CAGR/Max DD | -0.27 |
EPS (Earnings per Share)
Revenue
Description: CDW CDW
CDW Corporation provides information technology (IT) solutions in the United States, the United Kingdom, and Canada. It operates through three segments: Corporate, Small Business, and Public. The company offers discrete hardware and software products and services, as well as integrated IT solutions, including on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. It also provides hardware products comprising notebooks/mobile devices, tablets, network communications, collaboration hardware, data storage and servers, desktop computers, and other hardware; and software products, such as cloud solutions, software assurance, application suites, security, virtualization, collaboration and productivity applications, operating systems, and network management. In addition, the company offers advisory and design, software development, implementation, and managed services, as well as warranties. It serves business, government, education, and healthcare customers. The company was formerly known as CDW Computer Centers, Inc. and changed its name to CDW Corporation in June 2003. CDW Corporation was founded in 1984 and is based in Vernon Hills, Illinois.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -1.08 > 1.0 |
| NWC/Revenue: 5.68% < 20% (prev 9.04%; Δ -3.36% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.21b > Net Income 1.07b |
| Net Debt (5.71b) to EBITDA (1.95b): 2.93 < 3 |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (130.6m) vs 12m ago -2.83% < -2% |
| Gross Margin: 21.73% > 18% (prev 0.22%; Δ 2151 % > 0.5%) |
| Asset Turnover: 146.1% > 50% (prev 143.1%; Δ 3.00% > 0%) |
| Interest Coverage Ratio: 7.28 > 6 (EBITDA TTM 1.95b / Interest Expense TTM 227.4m) |
Altman Z'' 0.88
| A: 0.08 (Total Current Assets 8.50b - Total Current Liabilities 7.23b) / Total Assets 16.03b |
| B: -0.08 (Retained Earnings -1.27b / Total Assets 16.03b) |
| C: 0.11 (EBIT TTM 1.65b / Avg Total Assets 15.35b) |
| D: -0.10 (Book Value of Equity -1.37b / Total Liabilities 13.42b) |
| Altman-Z'' Score: 0.88 = B |
Beneish M -2.90
| DSRI: 1.14 (Receivables 6.87b/5.65b, Revenue 22.42b/21.00b) |
| GMI: 1.01 (GM 21.73% / 21.92%) |
| AQI: 0.95 (AQ_t 0.45 / AQ_t-1 0.48) |
| SGI: 1.07 (Revenue 22.42b / 21.00b) |
| TATA: -0.01 (NI 1.07b - CFO 1.21b) / TA 16.03b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of CDW shares?
As of February 27, 2026, the stock is trading at USD 123.39 with a total of 1,444,516 shares traded.
Over the past week, the price has changed by -0.13%, over one month by -2.66%, over three months by -14.12% and over the past year by -30.39%.
Over the past week, the price has changed by -0.13%, over one month by -2.66%, over three months by -14.12% and over the past year by -30.39%.
Is CDW a buy, sell or hold?
CDW has received a consensus analysts rating of 4.08.
Therefore, it is recommended to buy CDW.
- StrongBuy: 5
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CDW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 167.4 | 35.7% |
| Analysts Target Price | 167.4 | 35.7% |
CDW Fundamental Data Overview February 27, 2026
P/E Trailing = 15.5275
P/E Forward = 15.1515
P/S = 0.7106
P/B = 8.4686
P/EG = 1.53
Revenue TTM = 22.42b USD
EBIT TTM = 1.65b USD
EBITDA TTM = 1.95b USD
Long Term Debt = 5.62b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.39b USD (from shortTermDebt, last quarter)
Debt = 6.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.71b USD (from netDebt column, last quarter)
Enterprise Value = 21.65b USD (15.93b + Debt 6.33b - CCE 618.7m)
Interest Coverage Ratio = 7.28 (Ebit TTM 1.65b / Interest Expense TTM 227.4m)
EV/FCF = 19.89x (Enterprise Value 21.65b / FCF TTM 1.09b)
FCF Yield = 5.03% (FCF TTM 1.09b / Enterprise Value 21.65b)
FCF Margin = 4.85% (FCF TTM 1.09b / Revenue TTM 22.42b)
Net Margin = 4.76% (Net Income TTM 1.07b / Revenue TTM 22.42b)
Gross Margin = 21.73% ((Revenue TTM 22.42b - Cost of Revenue TTM 17.55b) / Revenue TTM)
Gross Margin QoQ = 22.76% (prev 21.88%)
Tobins Q-Ratio = 1.35 (Enterprise Value 21.65b / Total Assets 16.03b)
Interest Expense / Debt = 0.92% (Interest Expense 58.5m / Debt 6.33b)
Taxrate = 24.28% (89.6m / 369.1m)
NOPAT = 1.25b (EBIT 1.65b * (1 - 24.28%))
Current Ratio = 1.18 (Total Current Assets 8.50b / Total Current Liabilities 7.23b)
Debt / Equity = 2.43 (Debt 6.33b / totalStockholderEquity, last quarter 2.61b)
Debt / EBITDA = 2.93 (Net Debt 5.71b / EBITDA 1.95b)
Debt / FCF = 5.25 (Net Debt 5.71b / FCF TTM 1.09b)
Total Stockholder Equity = 2.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.95% (Net Income 1.07b / Total Assets 16.03b)
RoE = 42.94% (Net Income TTM 1.07b / Total Stockholder Equity 2.48b)
RoCE = 20.42% (EBIT 1.65b / Capital Employed (Equity 2.48b + L.T.Debt 5.62b))
RoIC = 15.38% (NOPAT 1.25b / Invested Capital 8.15b)
WACC = 7.60% (E(15.93b)/V(22.27b) * Re(10.34%) + D(6.33b)/V(22.27b) * Rd(0.92%) * (1-Tc(0.24)))
Discount Rate = 10.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.97%
[DCF] Terminal Value 79.68% ; FCFF base≈1.11b ; Y1≈1.12b ; Y5≈1.20b
[DCF] Fair Price = 132.1 (EV 22.91b - Net Debt 5.71b = Equity 17.20b / Shares 130.2m; r=7.60% [WACC]; 5y FCF grow 0.17% → 2.90% )
EPS Correlation: 0.34 | EPS CAGR: 4.23% | SUE: 0.87 | # QB: 1
Revenue Correlation: -28.90 | Revenue CAGR: -2.02% | SUE: 0.67 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.26 | Chg7d=+0.064 | Chg30d=+0.066 | Revisions Net=+3 | Analysts=10
EPS current Year (2026-12-31): EPS=10.55 | Chg7d=+0.042 | Chg30d=+0.045 | Revisions Net=-5 | Growth EPS=+5.3% | Growth Revenue=+2.9%
EPS next Year (2027-12-31): EPS=11.40 | Chg7d=+0.095 | Chg30d=+0.079 | Revisions Net=-1 | Growth EPS=+8.1% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +0.33 (6 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.9% (Discount Rate 10.3% - Earnings Yield 6.4%)
[Growth] Growth Spread = +1.2% (Analyst 5.1% - Implied 3.9%)
P/E Forward = 15.1515
P/S = 0.7106
P/B = 8.4686
P/EG = 1.53
Revenue TTM = 22.42b USD
EBIT TTM = 1.65b USD
EBITDA TTM = 1.95b USD
Long Term Debt = 5.62b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.39b USD (from shortTermDebt, last quarter)
Debt = 6.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.71b USD (from netDebt column, last quarter)
Enterprise Value = 21.65b USD (15.93b + Debt 6.33b - CCE 618.7m)
Interest Coverage Ratio = 7.28 (Ebit TTM 1.65b / Interest Expense TTM 227.4m)
EV/FCF = 19.89x (Enterprise Value 21.65b / FCF TTM 1.09b)
FCF Yield = 5.03% (FCF TTM 1.09b / Enterprise Value 21.65b)
FCF Margin = 4.85% (FCF TTM 1.09b / Revenue TTM 22.42b)
Net Margin = 4.76% (Net Income TTM 1.07b / Revenue TTM 22.42b)
Gross Margin = 21.73% ((Revenue TTM 22.42b - Cost of Revenue TTM 17.55b) / Revenue TTM)
Gross Margin QoQ = 22.76% (prev 21.88%)
Tobins Q-Ratio = 1.35 (Enterprise Value 21.65b / Total Assets 16.03b)
Interest Expense / Debt = 0.92% (Interest Expense 58.5m / Debt 6.33b)
Taxrate = 24.28% (89.6m / 369.1m)
NOPAT = 1.25b (EBIT 1.65b * (1 - 24.28%))
Current Ratio = 1.18 (Total Current Assets 8.50b / Total Current Liabilities 7.23b)
Debt / Equity = 2.43 (Debt 6.33b / totalStockholderEquity, last quarter 2.61b)
Debt / EBITDA = 2.93 (Net Debt 5.71b / EBITDA 1.95b)
Debt / FCF = 5.25 (Net Debt 5.71b / FCF TTM 1.09b)
Total Stockholder Equity = 2.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.95% (Net Income 1.07b / Total Assets 16.03b)
RoE = 42.94% (Net Income TTM 1.07b / Total Stockholder Equity 2.48b)
RoCE = 20.42% (EBIT 1.65b / Capital Employed (Equity 2.48b + L.T.Debt 5.62b))
RoIC = 15.38% (NOPAT 1.25b / Invested Capital 8.15b)
WACC = 7.60% (E(15.93b)/V(22.27b) * Re(10.34%) + D(6.33b)/V(22.27b) * Rd(0.92%) * (1-Tc(0.24)))
Discount Rate = 10.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.97%
[DCF] Terminal Value 79.68% ; FCFF base≈1.11b ; Y1≈1.12b ; Y5≈1.20b
[DCF] Fair Price = 132.1 (EV 22.91b - Net Debt 5.71b = Equity 17.20b / Shares 130.2m; r=7.60% [WACC]; 5y FCF grow 0.17% → 2.90% )
EPS Correlation: 0.34 | EPS CAGR: 4.23% | SUE: 0.87 | # QB: 1
Revenue Correlation: -28.90 | Revenue CAGR: -2.02% | SUE: 0.67 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.26 | Chg7d=+0.064 | Chg30d=+0.066 | Revisions Net=+3 | Analysts=10
EPS current Year (2026-12-31): EPS=10.55 | Chg7d=+0.042 | Chg30d=+0.045 | Revisions Net=-5 | Growth EPS=+5.3% | Growth Revenue=+2.9%
EPS next Year (2027-12-31): EPS=11.40 | Chg7d=+0.095 | Chg30d=+0.079 | Revisions Net=-1 | Growth EPS=+8.1% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +0.33 (6 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.9% (Discount Rate 10.3% - Earnings Yield 6.4%)
[Growth] Growth Spread = +1.2% (Analyst 5.1% - Implied 3.9%)